CYLD and the NEMO Zinc Finger Regulate Tumor Necrosis Factor Signaling and Early Embryogenesis

Overview

Journal J Biol Chem

Specialty Biochemistry

Date 2015 Jul 31

PMID 26224629

Citations 8

Authors

Yongge Zhao

Chi A Ma

Liming Wu

Kazuhiro Iwai

Jonathan D Ashwell

Eugene M Oltz

Dean W Ballard

Ashish Jain

Affiliations

Soon will be listed here.

Abstract

NF-κB essential modulator (NEMO) and cylindromatosis protein (CYLD) are intracellular proteins that regulate the NF-κB signaling pathway. Although mice with either CYLD deficiency or an alteration in the zinc finger domain of NEMO (K392R) are born healthy, we found that the combination of these two gene defects in double mutant (DM) mice is early embryonic lethal but can be rescued by the absence of TNF receptor 1 (TNFR1). Notably, NEMO was not recruited into the TNFR1 complex of DM cells, and consequently NF-κB induction by TNF was severely impaired and DM cells were sensitized to TNF-induced cell death. Interestingly, the TNF signaling defects can be fully rescued by reconstitution of DM cells with CYLD lacking ubiquitin hydrolase activity but not with CYLD mutated in TNF receptor-associated factor 2 (TRAF2) or NEMO binding sites. Therefore, our data demonstrate an unexpected non-catalytic function for CYLD as an adapter protein between TRAF2 and the NEMO zinc finger that is important for TNF-induced NF-κB signaling during embryogenesis.

Citing Articles

In the moonlight: non-catalytic functions of ubiquitin and ubiquitin-like proteases.

Campos Alonso M, Knobeloch K Front Mol Biosci. 2024; 11:1349509.

PMID: 38455765 PMC: 10919355. DOI: 10.3389/fmolb.2024.1349509.

The SUMOylation and ubiquitination crosstalk in cancer.

Li K, Xia Y, He J, Wang J, Li J, Ye M J Cancer Res Clin Oncol. 2023; 149(17):16123-16146.

PMID: 37640846 DOI: 10.1007/s00432-023-05310-z.

Integrative analyses of maternal plasma cell-free DNA nucleosome footprint differences reveal chromosomal aneuploidy fetuses gene expression profile.

Zhang M, Li K, Qu S, Guo Z, Wang Y, Yang X J Transl Med. 2022; 20(1):536.

PMID: 36401256 PMC: 9673457. DOI: 10.1186/s12967-022-03735-7.

Genotoxicity-Stimulated and CYLD-Driven Malignant Transformation.

Erol A Cancer Manag Res. 2022; 14:2339-2356.

PMID: 35958947 PMC: 9362849. DOI: 10.2147/CMAR.S373557.

The role of K63-linked polyubiquitination in cardiac hypertrophy.

Yan K, Ponnusamy M, Xin Y, Wang Q, Li P, Wang K J Cell Mol Med. 2018; 22(10):4558-4567.

PMID: 30102008 PMC: 6156430. DOI: 10.1111/jcmm.13669.

References

Temmerman S, Ma C, Zhao Y, Keenan J, Aksentijevich I, Fessler M . Defective nuclear IKKα function in patients with ectodermal dysplasia with immune deficiency. J Clin Invest. 2011; 122(1):315-26. PMC: 3248277. DOI: 10.1172/JCI42534. View

Wertz I, Dixit V . Regulation of death receptor signaling by the ubiquitin system. Cell Death Differ. 2009; 17(1):14-24. DOI: 10.1038/cdd.2009.168. View

Saito K, Kigawa T, Koshiba S, Sato K, Matsuo Y, Sakamoto A . The CAP-Gly domain of CYLD associates with the proline-rich sequence in NEMO/IKKgamma. Structure. 2004; 12(9):1719-28. DOI: 10.1016/j.str.2004.07.012. View

Doi T, Marino M, Takahashi T, Yoshida T, Sakakura T, Old L . Absence of tumor necrosis factor rescues RelA-deficient mice from embryonic lethality. Proc Natl Acad Sci U S A. 1999; 96(6):2994-9. PMC: 15883. DOI: 10.1073/pnas.96.6.2994. View

Bignell G, Warren W, Seal S, Takahashi M, Rapley E, Barfoot R . Identification of the familial cylindromatosis tumour-suppressor gene. Nat Genet. 2000; 25(2):160-5. DOI: 10.1038/76006. View

Cao Z, Tanaka M, Regnier C, Rothe M, Woronicz J, Fuentes M . NF-kappa B activation by tumor necrosis factor and interleukin-1. Cold Spring Harb Symp Quant Biol. 2001; 64:473-83. DOI: 10.1101/sqb.1999.64.473. View

Jain A, Ma C, Liu S, Brown M, Cohen J, Strober W . Specific missense mutations in NEMO result in hyper-IgM syndrome with hypohydrotic ectodermal dysplasia. Nat Immunol. 2001; 2(3):223-8. DOI: 10.1038/85277. View

Ware C . The TNF superfamily. Cytokine Growth Factor Rev. 2003; 14(3-4):181-4. DOI: 10.1016/s1359-6101(03)00032-7. View

Micheau O, Tschopp J . Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes. Cell. 2003; 114(2):181-90. DOI: 10.1016/s0092-8674(03)00521-x. View

10.

Trompouki E, Hatzivassiliou E, Tsichritzis T, Farmer H, Ashworth A, Mosialos G . CYLD is a deubiquitinating enzyme that negatively regulates NF-kappaB activation by TNFR family members. Nature. 2003; 424(6950):793-6. DOI: 10.1038/nature01803. View

11.

Wu C, Conze D, Li T, Srinivasula S, Ashwell J . Sensing of Lys 63-linked polyubiquitination by NEMO is a key event in NF-kappaB activation [corrected]. Nat Cell Biol. 2006; 8(4):398-406. DOI: 10.1038/ncb1384. View

12.

Baker R, Hayden M, Ghosh S . NF-κB, inflammation, and metabolic disease. Cell Metab. 2011; 13(1):11-22. PMC: 3040418. DOI: 10.1016/j.cmet.2010.12.008. View

13.

Ma C, Wang H, Temmerman S, Zhao Y, Wu L, Hornung R . Dendritic cells from humans with hypomorphic mutations in IKBKG/NEMO have impaired mitogen-activated protein kinase activity. Hum Mutat. 2011; 32(3):318-24. PMC: 3134100. DOI: 10.1002/humu.21439. View

14.

Zhao Y, Thornton A, Kinney M, Ma C, Spinner J, Fuss I . The deubiquitinase CYLD targets Smad7 protein to regulate transforming growth factor β (TGF-β) signaling and the development of regulatory T cells. J Biol Chem. 2011; 286(47):40520-30. PMC: 3220473. DOI: 10.1074/jbc.M111.292961. View

15.

Li Q, Van Antwerp D, Mercurio F, Lee K, Verma I . Severe liver degeneration in mice lacking the IkappaB kinase 2 gene. Science. 1999; 284(5412):321-5. DOI: 10.1126/science.284.5412.321. View

16.

Brummelkamp T, Nijman S, Dirac A, Bernards R . Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-kappaB. Nature. 2003; 424(6950):797-801. DOI: 10.1038/nature01811. View

17.

Temmerman S, Ma C, Borges L, Kubin M, Liu S, Derry J . Impaired dendritic-cell function in ectodermal dysplasia with immune deficiency is linked to defective NEMO ubiquitination. Blood. 2006; 108(7):2324-31. PMC: 1895566. DOI: 10.1182/blood-2006-04-017210. View

18.

Zhang J, Stirling B, Temmerman S, Ma C, Fuss I, Derry J . Impaired regulation of NF-kappaB and increased susceptibility to colitis-associated tumorigenesis in CYLD-deficient mice. J Clin Invest. 2006; 116(11):3042-9. PMC: 1616194. DOI: 10.1172/JCI28746. View

19.

Annunziata C, Davis R, Demchenko Y, Bellamy W, Gabrea A, Zhan F . Frequent engagement of the classical and alternative NF-kappaB pathways by diverse genetic abnormalities in multiple myeloma. Cancer Cell. 2007; 12(2):115-30. PMC: 2730509. DOI: 10.1016/j.ccr.2007.07.004. View

20.

Ni C, Wu Z, Florence W, Parekh V, Arrate M, Pierce S . Cutting edge: K63-linked polyubiquitination of NEMO modulates TLR signaling and inflammation in vivo. J Immunol. 2008; 180(11):7107-11. PMC: 2601684. DOI: 10.4049/jimmunol.180.11.7107. View